Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn
Research Article

THE NATURE OF ADRENERGIC NERVE MEDIATORS

U. S. von EULER
Pharmacological Reviews September 1951, 3 (3) 247-277;
U. S. von EULER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The chief points in the present concept of the adrenergic nerve mediators may be briefly summarized as follows: 1. Convincing evidence has been produced to show that l-noradrenaline is the chief adrenergic nerve mediator in mammals. In addition i-adrenaline occurs admixed in various small amounts with the noradrenaline. The hypothesis of purelyexcitatory or purely inhibitory sympathins is no longer tenable. The liberation of other related substances such as hydroxytyramine, tyramine and oxidation products of dihydroxyphenyl derivatives in adrenergic nerve activity has not been proven in mammals. 2. The adrenergic nerve mediators l-noradrenaline and i-adrenaline can account for most actions observed on stimulation of adrenergic nerves. 3. Noradrenaline and adrenaline are formed in the adrenergic neurons and appear in small quantities in the nerve trunks and in larger amounts in the innervated organs, presumably occurring in the terminal nerve structures. 4. The adrenergic nerve mediators disappear from an organ after degeneration of the nerves but reappear on nerve regeneration. 5. There is some evidence in favour of the formation of noradrenaline by decarboxylation of dihydroxyphenylalanine and subsequent introduction of a hydroxyl group in the side chain of the hydroxytyramine so formed. 6. The adrenergic nerve mediators are rapidly inactivated in the tissues by enzymes (amine oxydase and catechol oxidase). A smaller part is excreted in free or conjugated form in the urine. 7. The physiological actions of noradrenaline and adrenaline differ in many important respects. The main function of noradrenaline seems to be the normal control of the circulation, while adrenaline produces various effects in conditions of stress and emergency.

PharmRev articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Pharmacological Reviews
Vol. 3, Issue 3
1 Sep 1951
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Pharmacological Reviews article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
THE NATURE OF ADRENERGIC NERVE MEDIATORS
(Your Name) has forwarded a page to you from Pharmacological Reviews
(Your Name) thought you would be interested in this article in Pharmacological Reviews.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research Article

THE NATURE OF ADRENERGIC NERVE MEDIATORS

U. S. von EULER
Pharmacological Reviews September 1, 1951, 3 (3) 247-277;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research Article

THE NATURE OF ADRENERGIC NERVE MEDIATORS

U. S. von EULER
Pharmacological Reviews September 1, 1951, 3 (3) 247-277;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics